enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Anaphylaxis - Wikipedia

   en.wikipedia.org/wiki/Anaphylaxis

   Anaphylactoid reaction, non-immune anaphylaxis, or pseudoanaphylaxis, is a type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation. [ 10 ] [ 42 ] Non-immune anaphylaxis is the current term, as of 2018, used by the World Allergy Organization [ 42 ] with some recommending that the old ...

3. Anti-allergic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-allergic_agent

   The most common anaphylactic reactions are induced by foods, insect stings and medications. [23] Adrenaline is both a hormone and a medication which plays an important role in the body's "fight-or-flight" response (the acute stress response). It is used to treat anaphylaxis as it provides immediate symptomatic relief.

4. EpiPen Alternative for Anaphylaxis Approved by FDA - AOL

   www.aol.com/epipen-alternative-anaphylaxis...

   As a result, Neffy provides an important treatment option and addresses an unmet need.” As the Mayo Clinic explains, “Anaphylaxis is a severe, life-threatening allergic reaction. It can happen ...

5. Hypersensitivity - Wikipedia

   en.wikipedia.org/wiki/Hypersensitivity

   The treatment of immediate hypersensitivity reactions includes the management of anaphylaxis with intramuscular adrenaline (epinephrine), oxygen, intravenous (IV) antihistamine, support blood pressure with IV fluids, avoid latex gloves and equipment in patients who are allergic, and surgical procedures such as tracheotomy if there is severe ...

6. FDA approves medication used to treat asthma for use in ...

   www.aol.com/news/fda-approves-medication-used...

   The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.

7. ALK licenses rights to neffy®, the first approved adrenaline ...

   lite.aol.com/tech/story/0022/20241109/1001012370.htm

   Emergency treatment of life-threatening allergic reactions has strong scientific and commercial ties to our existing portfolio and prescriber base. We are convinced that neffy ® will transform anaphylaxis, benefitting patients at risk and leading to a significant expansion of the market.” Exclusive rights to new indications ARS Pharma is ...

8. ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic ...

   www.aol.com/ars-pharmaceuticals-inks-licensing...

   ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024. Vandana Singh. November 11, 2024 at 9:41 AM.

9. Type I hypersensitivity - Wikipedia

   en.wikipedia.org/wiki/Type_I_hypersensitivity

   Type I hypersensitivity (or immediate hypersensitivity), in the Gell and Coombs classification of allergic reactions, is an allergic reaction provoked by re-exposure to a specific type of antigen referred to as an allergen. [1] Type I is distinct from type II, type III and type IV hypersensitivities. The relevance of the Gell and Coombs ...